. 2015 Aug 27;14:331. doi: 10.1186/s12936-015-0851-8

Table 3.

Covariates associated with prescription of an anti-malarial drug among children with only negative malaria tests results

Covariates	Proportion prescribed an antimalarial (%)	Univariate analysis			Multivariate analysis
Covariates	Proportion prescribed an antimalarial (%)	OR	95 % CI	p value	aOR	95 % CI	p value
Hospital
Kabale	513/3544 (14.5)		Reference			Reference
Tororo	1154/5541 (20.8)	1.55	1.39-1.74	<0.001	1.72	1.44-2.04	<0.001
Apac	814/2841 (28.7)	2.37	2.10-2.69	<0.001	2.69	2.23-3.24	<0.001
Kambuga	877/2196 (39.9)	3.93	3.46-4.46	<0.001	3.39	2.88-4.00	<0.001
Jinja	5661/10,571 (53.6)	6.81	6.16-7.54	<0.001	7.45	6.37-8.71	<0.001
Mubende	2958/5517 (53.6)	6.83	6.13-7.60	<0.001	7.19	6.17-8.39	<0.001
Age
<6 months	692/4062 (17.0)		Reference			Reference
6–12 months	2440/6272 (38.9)	3.10	2.82–3.41	<0.001	3.82	3.43–4.26	<0.001
≥12 months	8840/19,866 (44.5)	3.90	3.58–4.26	<0.001	4.89	4.45–5.41	<0.001
Fever^a
Absent	487/3982 (12.2)		Reference			Reference
Present	11,490/26,216 (43.8)	5.60	5.08–6.18	<0.001	5.41	4.86–6.02	<0.001
Clinical findings suggestive of complicated malaria^b
Absent	4329/14,819 (29.2)		Reference			Reference
Present	7648/15,391 (49.7)	2.39	2.28–2.51	<0.001	1.94	1.83–2.06	<0.001

Clustering on the day of admission adjusted using GEE

^aHistory of fever or elevated temperature

^bHistory of or witnessed convulsions, altered consciousness, tea coloured urine, jaundice, unconsciousness, lethargy, inability to sit, or severe pallor